Keynote Address: Future of the Global HealthCare Industry;G. Steven Burrill, Founder and CEO of Burrill & Co.
Abstract: A new healthcare ecosystem is evolving arising from technology and market convergence that will have a dramatic impact on global drug development and companies are having to adapt to this new world made more complex by impending healthcare reform and the shifting emphasis from treating sickness to encouraging wellness.
9:30 - 10:15 AM
Keynote Address: Partnering Opportunities in Indian Life Science – Why, What, When and How; Bala Manian, Founder and CEO of Reametrix
Abstract: This talk will give an overview of the opportunity landscape, analyze the driving forces behind this movement, explain the barriers to the fulfillment of this potential and outline the external factors, such as financing , acting as drivers. The object is to present balanced view of the opportunity as well as its inherent risks. Dr. Manian will also describe funding initiatives by the Indian government to promote novel drug development, which could be of interest to US biotech companies seeking to partner with Indian companies.
10:15 – 11:00 AM
Partnering Showcase 1: BioCon’s Drug Development Partnerships; Abhijit Zutshi, Head of BioCon’s North American Operations
Abstract: BioCon has aggressively pursued cross border partnerships and this talk will discuss the rationale and structure underlying BioCon’s collaborations. Most recently, BioCon announced a partnership with Amylin Pharmaceuticals to develop and market a biotech diabetes drug. The companies will share development costs. Amylin, will provide technology that can combine two hormones into one drug, while BioCon will manufacture the product and provide experience in developing diabetes treatments. BioCon also has partnerships with Mylan for the development of BioSimilars, with Vaccinex for the co-development of antibody therapeutics, and with Johns Hopkins University (Iatrica) to access a new technology platform.
11:00 - 12:00 PM
Panel 1: Cross-Border Partnership Models Moderator:Ravi Kiron, COO Adjuvant Panelists:P.M. Murali, Managing Director, Evolva India; Shehnaaz Suliman, Senior Director Corporate Development, Gilead Sciences, Mark Ravera, Director Global Licensing & Business Development, Glenmark Sciences Inc.
Panel Description: Globalization and the internet have shrunk our world. We are now instantly connected to people halfway across the globe. In this age of interconnectivity and economic turbulence, cross border partnership models are increasingly being adopted by life science companies as an innovative paradigm to identify new markets, access novel skills, technology, or products, and to defray fixed costs and resources. The panel will address the following:
• Growth and development of the life science industry in emerging markets
• Strategic reasons that have resulted in cross-border alliances
• Benefits and Risks of such alliances from both sides of the table
• Critical success factors in these alliance models
12:00 – 12:45 PM
Lunch and Networking
12:45 - 1:30 PM
Partnering Showcase 2: Napo Pharmaceutical’s Drug Development Partnership with Glenmark Pharmaceuticals;Lisa Conte, Founder and CEO Napo Pharmaceuticals and designate of Gelnmark Pharmaceuticals
Abstract: In 2005, Napo signed a licensing agreement with Glenmark for Napo’s anti-diarrhea GI drug, Crofelemer (CRO). Napo has granted development and commercialization rights to Glenmark in their territories for CRO in HIV, pediatric and infectious disease indications. The companies will speak about their experiences in their four year partnership.
1:30 - 2:15 PM
Panel 2: Legal and Regulatory Frameworks in Structuring Cross-border partnerships Moderator:Shalabh Gupta, Senior Strategy Manager, Genentech Panelists:Anie Roche, Partner, Intellectual Property Law, WSGR, Vaibhav Parikh, Head of the Technology Law Practice, Nishith Desai Associates, Teresa Rea, Partner, Intellectual Property Law, Crowell & Moring LLP
Panel Description: The goal of this panel is to identify cross border business opportunities in this space for entrepreneurs and biopharma executives. In a cross border transaction, the inherent challenges of structuring a deal are complicated by each country’s unique regulatory framework. The panelists will share relevant aspects of transactions in which they have played a key role. This panel will :
• Describe existing cross border business models, and developing new paradigms
• Discuss potential outcomes of the regulatory uncertainties related to the Hatch Waxman Act, which impact the approval pathways for BioSimilars
• Identify the key regulatory and legal elements that aided the success of real world partnerships
• Flag common blind spots in structuring international transactions, and potential remedies
2:15 - 2:45 PM
New Frontiers: Companion Diagnostics in Drug Development;Meeta Patnaik, MD, Vice President Companion Diagnostics, Laboratory Corporation of America
Abstract: Companion diagnostics and personalized medicine are intricately linked. The growing role of biomarkers in the later stages of drug development and the validation and commercialization of drug/diagnostic combos will be discussed. In particular the global aspects and needs for standardization and accessibility (regulatory and reimbursement) of these tests in countries outside the USA and Europe is a major concern and should be dealt with early on in the development program.
This is your optimal opportunity to learn about the vibrant life science environment in India and explore new business opportunities. Meet colleagues who have successfully executed strategic relationships and partnerships with Indian companies and hear their stories first hand. This milestone event will showcase Indian companies pursuing novel drug development as well as select service businesses that have an extensive track record of establishing US and European collaborations.
Conference Host: EPPIC, the premier India-oriented life science organization in the Bay Area, is hosting this event in conjunction with EBD Group’s widely anticipated event, BioPharm America 2009, the 2nd Annual International Partnering Conference ( www.ebdgroup.com/bpa ). Avail yourselves of this unique opportunity to explore new horizons and grow your global network.
The Target Audience: includes attendees from the West (US and Europe) who want to work successfully with Indian companies, as well as Indian companies who are interested in collaborating with Western companies. Today, more than ever before, ambient economic pressures compel us to think and work globally. Join us for India LifeScience Day and launch or expand your Indian network.
Conference Registration and Logistics: India LifeScience Day will immediately follow EBD’s BioPharm America 2009, the 2nd Annual International Partnering Conference ( www.ebdgroup.com/bpa ). The conference venue is the Marriott Hotel, San Francisco. Take advantage of the highly attractive pricing of $150 to attend the India LifeScience Day on September 18, 2009. EPPIC members will receive a significant discount of $100 registration fee (not an EPPIC member? Join EPPIC today: www.eppicglobal.org/MemIndividual.asp ). To register for this event, Click here.
In addition, we have negotiated a special $200 discount for those attending the India LifeScience Day on the registration fee of the EBD Group conference. To take advantage of this discount, when registering for BioPharm America, please enter “EPPIC discount” in the comment field.
Full fee registrants of BioPharm America will be entitled to attend the India LifeScience Day at no additional charge.
Agenda SneakPeak: India LifeScience Day will begin with a preeminent expert providing an up-to-date landscape of the life science industry in India today. Following this, you will hear from a series of Indian and US/European companies who have forged successful partnerships. At this conference you will have the unusual opportunity to hear from both parties in the partnership and have ample opportunities to ask questions and network. You will also hear from a spectrum of investors about financing Indian and cross-border opportunities. You will surely not want to miss this conference that truly focuses on collaborating and partnering between US/Europe and India. We will send you updates on registration and promise you a truly engaging agenda with outstanding speakers. Please save the date!
Registration: To register for this event, Click here
